In another example, Shi labeled a humanized anti-GPC3 monoclonal antibody with ICG to create a NIR-II fluorescent probe (GPC3-ICG) designed to specifically target hepatocellular carcinoma (HCC) (Figure 3A). Here, GPC3 is linked to hepatocellular carcinoma.